Search Results

There are 16965 results for: content related to: Variation in  OPRM1  and Risk of Suicidal Behavior in Drug-Dependent Individuals

  1. Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 147B, Issue 7, 5 October 2008, Pages: 1028–1039, Xingguang Luo, Lingjun Zuo, Henry Kranzler, Huiping Zhang, Shuang Wang and Joel Gelernter

    Version of Record online : 22 JAN 2008, DOI: 10.1002/ajmg.b.30701

  2. You have free access to this content
    Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1718–1725, Yu-Chang Liu and Wei-Shu Wang

    Version of Record online : 11 AUG 2011, DOI: 10.1002/cncr.26430

  3. The genetic influences on oxycodone response characteristics in human experimental pain

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 4, August 2015, Pages: 417–425, Anne E. Olesen, Hiroe Sato, Lecia M. Nielsen, Camilla Staahl, Joanne Droney, Sophy Gretton, Ruth Branford, Asbjørn M. Drewes, Lars Arendt-Nielsen, Julia Riley and Joy Ross

    Version of Record online : 22 JUN 2015, DOI: 10.1111/fcp.12128

  4. The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review

    The American Journal on Addictions

    Volume 24, Issue 1, January 2015, Pages: 15–23, Isabelle E. Bauer, Jair C. Soares and David A. Nielsen

    Version of Record online : 30 MAR 2015, DOI: 10.1111/ajad.12172

  5. OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach

    Alcoholism: Clinical and Experimental Research

    Volume 33, Issue 3, March 2009, Pages: 383–393, Gabor Oroszi, Raymond F. Anton, Stephanie O’Malley, Robert Swift, Helen Pettinati, David Couper, Qiaoping Yuan and David Goldman

    Version of Record online : 2 DEC 2008, DOI: 10.1111/j.1530-0277.2008.00846.x

  6. Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review

    Pain Practice

    Volume 15, Issue 6, July 2015, Pages: 580–594, Lecia M. Nielsen, Anne E. Olesen, Ruth Branford, Lona L. Christrup, Hiroe Sato and Asbjørn M. Drewes

    Version of Record online : 8 SEP 2014, DOI: 10.1111/papr.12232

  7. Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex

    Addiction Biology

    Volume 18, Issue 6, November 2013, Pages: 1003–1012, Marloes Kleinjan, Evelien A. Poelen, Rutger C. M. E. Engels and Maaike Verhagen

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1369-1600.2011.00422.x

  8. OPRM1 and CYP2B6 Gene Variants as Risk Factors in Methadone-Related Deaths

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 3, September 2010, Pages: 383–389, H Bunten, W J Liang, D J Pounder, C Seneviratne and D Osselton

    Version of Record online : 28 JUL 2010, DOI: 10.1038/clpt.2010.127

  9. Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 3, May 2013, Pages: 258–262, Alissa J. Cooper, Karl Rickels and Falk W. Lohoff

    Version of Record online : 8 MAY 2013, DOI: 10.1002/hup.2317

  10. Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study

    The American Journal on Addictions

    Volume 24, Issue 4, June 2015, Pages: 329–335, Eric A. Woodcock, Leslie H. Lundahl, Margit Burmeister and Mark K. Greenwald

    Version of Record online : 24 APR 2015, DOI: 10.1111/ajad.12187

  11. You have free access to this content
    Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*

    Anaesthesia

    Volume 63, Issue 12, December 2008, Pages: 1288–1295, C.-J. Huang, H.-F. Liu, N.-Y. Su, Y.-W. Hsu, C.-H. Yang, C.-C. Chen and P.-S. Tsai

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2044.2008.05760.x

  12. Naltrexone Modification of Drinking Effects in a Subacute Treatment and Bar-Lab Paradigm: Influence of OPRM1 and Dopamine Transporter (SLC6A3) Genes

    Alcoholism: Clinical and Experimental Research

    Volume 36, Issue 11, November 2012, Pages: 2000–2007, Raymond F. Anton, Konstantin K. Voronin, Patrick K. Randall, Hugh Myrick and Abraham Tiffany

    Version of Record online : 2 MAY 2012, DOI: 10.1111/j.1530-0277.2012.01807.x

  13. The opioid system in alcohol and drug dependence: Family-based association study

    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

    Volume 144B, Issue 7, 5 October 2007, Pages: 877–884, Xiaoling Xuei, Leah Flury-Wetherill, Laura Bierut, Danielle Dick, John Nurnberger Jr, Tatiana Foroud and Howard J Edenberg

    Version of Record online : 14 MAY 2007, DOI: 10.1002/ajmg.b.30531

  14. You have free access to this content
    Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults

    Addiction Biology

    Volume 21, Issue 1, January 2016, Pages: 125–135, Christian S. Hendershot, Eric D. Claus and Vijay A. Ramchandani

    Version of Record online : 20 JUL 2014, DOI: 10.1111/adb.12165

  15. The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review

    The American Journal on Addictions

    Isabelle E. Bauer, Jair C. Soares and David A. Nielsen

    Version of Record online : 21 NOV 2014, DOI: 10.1111/j.1521-0391.2014.12172.x

  16. Association of ABCB1/MDR1 and OPRM1 Gene Polymorphisms With Morphine Pain Relief

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 559–566, D Campa, A Gioia, A Tomei, P Poli and R Barale

    Version of Record online : 26 SEP 2007, DOI: 10.1038/sj.clpt.6100385

  17. You have free access to this content
    OPRM1 gene variants modulate amphetamine-induced euphoria in humans

    Genes, Brain and Behavior

    Volume 10, Issue 2, March 2011, Pages: 199–209, A. M. Dlugos, A. Hamidovic, C. Hodgkinson, P. H. Shen, D. Goldman, A. A. Palmer and H. de Wit

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1601-183X.2010.00655.x

  18. Elucidation of mu-opioid gene structure: How genetics can help predict therapeutic response to opioids

    European Journal of Pain Supplements

    Volume 5, Issue S2, November 2011, Pages: 433–438, Luda Diatchenko, J. Elliott Robinson and William Maixner

    Version of Record online : 17 JAN 2012, DOI: 10.1016/j.eujps.2011.08.022

  19. The Role of the Asn40Asp Polymorphism of the Mu Opioid Receptor Gene (OPRM1) on Alcoholism Etiology and Treatment: A Critical Review

    Alcoholism: Clinical and Experimental Research

    Volume 36, Issue 3, March 2012, Pages: 385–394, Lara A. Ray, Christina S. Barr, Julie A. Blendy, David Oslin, David Goldman and Raymond F. Anton

    Version of Record online : 6 SEP 2011, DOI: 10.1111/j.1530-0277.2011.01633.x

  20. Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis

    Addiction Biology

    Volume 17, Issue 3, May 2012, Pages: 505–512, Antonio-Javier Chamorro, Miguel Marcos, José-Antonio Mirón-Canelo, Isabel Pastor, Rogelio González-Sarmiento and Francisco-Javier Laso

    Version of Record online : 19 APR 2012, DOI: 10.1111/j.1369-1600.2012.00442.x